# X-Seal EU Post-Market Clinical Follow-Up Protocol

> **NCT02406612** · NA · COMPLETED · sponsor: **Essential Medical, Inc.** · enrollment: 47 (actual)

## Conditions studied

- Femoral Arteriotomy Closure

## Interventions

- **DEVICE:** X-Seal 6F Vascular Closure Device

## Key facts

- **NCT ID:** NCT02406612
- **Lead sponsor:** Essential Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-02
- **Final completion:** 2016-06
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2018-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02406612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02406612, "X-Seal EU Post-Market Clinical Follow-Up Protocol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02406612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*